Fractyl Health, Inc. (GUTS)
$4.42+4.49%Close
SELLCRISIS · day 23
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $319M
- Beta
- 2.33
- P/E (TTM)
- -0.35
- Short % float
- 7.32%
- Days to cover
- 1.2
- SI change
- -20.3%
- 1W
- -9.43%
- 1M
- -42.75%
- vs SPY 1W
- -10.59%
- vs SPY 1M
- -45.74%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on GUTS?
- LOPJLB’s latest quantitative signal on Fractyl Health, Inc. (GUTS) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is GUTS in?
- Fractyl Health, Inc. (GUTS) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Fractyl Health, Inc. (GUTS) do?
- Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It develops Rejuva, a novel a…